CORE--VIROLOGY CORE LABORATORY
核心--病毒学核心实验室
基本信息
- 批准号:3791162
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The purpose of this application is to demonstrate the capability of The
Ohio State University AIDS Clinical Trials Unit's virology laboratory to
function as one of the core Virology Laboratories for the ACTU network.
This ACTG laboratory will perform the protocol virologic monitoring as
mandated by the ACTG protocols and Virology Core Committee. These include
HIV antigen testing, HIV cultures and the measurement and evaluation of
other viral markers as diagnostic methods evolve. Participation in quality
assurance programs will standardize and validate assay results.
Prior experience in the performance of a large number of these assays and
the maintenance of a high level of proficiency and quality control for the
last three years attests to the capability of this laboratory to perform
this work. The OSU ACTU virology laboratory was/is not primarily organized
as a basic research laboratory doing experimental studies ut as a clinical
laboratory developing standardized assays. This concept is most important
in performing the protocol mandated virologic assays where the goal is
providing consistently accurate results using a consensus assay on a large
number of specimens. Laboratory certifications from a variety of
organizations attests to achieving this goal. Nevertheless the laboratory
still has performed well in the application and development of virologic
assays in the clinical setting and currently participates in the on-going
evaluation of new quantitative virologic culture techniques.
In addition, the virology facilities were recently constructed and were
built with an expansion in function expected. Thus, both space and
equipment are ample to safely handle the expected increase in specimen
load.
此应用程序的目的是演示的能力
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL F PARA其他文献
MICHAEL F PARA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL F PARA', 18)}}的其他基金
ASSESS SAFETY, TOLERANCE, PHARMACOKINETICS AND DEV. OF DECR. HIV-1 TO ATV
评估安全性、耐受性、药代动力学和开发。
- 批准号:
3761442 - 财政年份:
- 资助金额:
-- - 项目类别:
A PHASE 1 CONCENTRATION-TARGETED MULTIDOSE STUDY OF ATEVIRDINE MESYLATE
甲磺酸阿特韦啶的 1 期浓度目标多剂量研究
- 批准号:
3761441 - 财政年份:
- 资助金额:
-- - 项目类别:














{{item.name}}会员




